Heritability of retinal drusen in the Copenhagen Twin Cohort Eye Study.


Journal

Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102

Informations de publication

Date de publication:
Dec 2022
Historique:
revised: 22 02 2022
received: 25 11 2021
accepted: 12 03 2022
pubmed: 25 3 2022
medline: 15 11 2022
entrez: 24 3 2022
Statut: ppublish

Résumé

To study age- and sex-adjusted heritability of small hard drusen and early age-related macular degeneration (AMD) in a population-based twin cohort. This was a single-centre, cross-sectional, classical twin study with ophthalmic examination including refraction, biometry, best-corrected visual acuity assessment, colour and autofluorescence fundus photography, and fundus optical coherence tomography. Grading and categorization of drusen was by diameter and location. The study enrolled 176 same-sex pairs of twins of mean (SD) age 58.6 (9.9) years. The prevalence of the four phenotypes ≥20 small hard macular drusen (largest diameter < 63 μm), ≥20 small hard extramacular drusen, intermediate drusen (63-125 μm) anywhere, and large drusen (>125 μm) anywhere was 12.4%, 36.4%, 5.8%, and 8.4%, respectively, and the respective heritabilities, adjusted for age and sex, were 78.2% [73.5-82.9], 69.1% [62.3-75.9], 30.1% [4.1-56.1], and 65.6% [26.4-100]. Age trajectory analysis supported a gradual transition to larger numbers of small hard drusen with increasing age. The heritability of ≥20 small hard drusen was markedly lower than the 99% found in the 40% overlapping twin cohort that was seen 20 years earlier. Numerous (≥20) small hard drusen and larger drusen that fit the definition of dry AMD were highly heritable. Small hard drusen counts increased with age. Decreasing heritability with increasing age suggests that the impact of behavioural and environmental factors on the development of small hard drusen increases with age.

Identifiants

pubmed: 35322936
doi: 10.1111/aos.15136
pmc: PMC9790204
doi:

Types de publication

Twin Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1561-e1568

Subventions

Organisme : Aase og Ejnar Danielsens Fond
ID : 18-10-0698
Organisme : Alfred-Vogt Foundation
Organisme : Beckett-Fonden
ID : 19-2-3490
Organisme : Einar Willumsen Foundation
ID : 500028
Organisme : H2020 European Research Council
ID : 780989
Organisme : Helsefonden
ID : 19-B-0063
Organisme : P. Carl Petersens Fond
ID : 19102
Organisme : Rigshospitalet
ID : E-23334-02
Organisme : VELUX Foundation
ID : 00028975
Organisme : OPUS Foundation

Informations de copyright

© 2022 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Références

Ophthalmology. 2002 Apr;109(4):730-6
pubmed: 11927430
Arch Ophthalmol. 2003 Jun;121(6):785-92
pubmed: 12796248
Diabetologia. 2003 Sep;46(9):1276-83
pubmed: 12898014
Trans Am Ophthalmol Soc. 1994;92:775-843
pubmed: 7886884
Ophthalmic Surg. 1985 Oct;16(10):648-51
pubmed: 2415894
Ophthalmology. 2001 Apr;108(4):697-704
pubmed: 11297486
Ophthalmol Retina. 2021 Sep;5(9):910-917
pubmed: 33309963
Acta Ophthalmol. 2016 Nov;94(7):657-662
pubmed: 27502478
Stat Med. 2014 Mar 30;33(7):1193-204
pubmed: 24132877
PLoS One. 2013;8(1):e53830
pubmed: 23326517
Invest Ophthalmol Vis Sci. 2010 May;51(5):2317-21
pubmed: 20007824
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1200-9
pubmed: 18326750
Ophthalmology. 2016 Jun;123(6):1297-308
pubmed: 26896123
Science. 2005 Apr 15;308(5720):421-4
pubmed: 15761121
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):833-8
pubmed: 17251485
Arch Ophthalmol. 2005 Mar;123(3):321-7
pubmed: 15767473
Sci Rep. 2019 Aug 15;9(1):11906
pubmed: 31417165
Eye (Lond). 2021 Jan;35(1):121-133
pubmed: 33208847
Science. 2005 Apr 15;308(5720):419-21
pubmed: 15761120
Arch Ophthalmol. 1989 Jun;107(6):847-52
pubmed: 2786408
Acta Ophthalmol Scand. 1999 Aug;77(4):422-5
pubmed: 10463414
Science. 2005 Apr 15;308(5720):385-9
pubmed: 15761122
Arch Ophthalmol. 2003 Dec;121(12):1728-37
pubmed: 14662593
Arch Ophthalmol. 1994 Jul;112(7):932-7
pubmed: 8031273
Br J Ophthalmol. 1999 Mar;83(3):358-68
pubmed: 10365048
Hum Mol Genet. 2005 Nov 1;14(21):3227-36
pubmed: 16174643
Arch Ophthalmol. 2003 May;121(5):658-63
pubmed: 12742843
Arch Ophthalmol. 2003 Apr;121(4):519-26
pubmed: 12695249
Arch Ophthalmol. 1995 Mar;113(3):301-8
pubmed: 7534060
J Clin Med. 2015 Mar;4(3):424-40
pubmed: 25905023

Auteurs

Mohamed Belmouhand (M)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Healthy and Medical Science, University of Copenhagen, Copenhagen, Denmark.

Simon Paul Rothenbuehler (SP)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Jacob B Hjelmborg (JB)

Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
The Danish Twin Research Center, University of Southern Denmark, Odense, Denmark.

Sami Dabbah (S)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Department of Ophthalmology, Odense University Hospital, Odense, Denmark.

Jakob Bjerager (J)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.

Birgit Agnes Sander (BA)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.

Christine Dalgård (C)

The Danish Twin Research Center, University of Southern Denmark, Odense, Denmark.
Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.

Michael Larsen (M)

Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Healthy and Medical Science, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH